InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Sjogren Eric, Vice-Président Senior, Découverte de Médicaments. Officer active across 1 company, notably Calithera Biosciences, Inc.. In total, 5 disclosures have been published. Activity tracked since 27 October 2021. The latest transaction was disclosed on 23 January 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Eric Sjogren is Senior Vice President, Drug Discovery at Calithera Biosciences, Inc. He oversees research and development initiatives, contributing to innovation and the creation of new treatments in the biopharmaceutical sector.